{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:26:00Z","timestamp":1707524760690},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,29]]},"DOI":"10.7759\/cureus.29745","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T16:05:57Z","timestamp":1664467557000},"source":"Crossref","is-referenced-by-count":0,"title":["A Lymphocytic Variant of Hypereosinophilic Syndrome Presenting With Isolated Cutaneous Manifestations"],"prefix":"10.7759","author":[{"given":"Oumayma","family":"Kamal Idrissi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouzia","family":"Hali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FatimZahra","family":"El Fatoiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumiya","family":"Chiheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00216","article-title":"(A critical appraisal of) classification of hypereosinophilic disorders","volume":"4","author":"Kahn JE","year":"2017","unstructured":"Kahn JE, Groh M, Lef\u00e8vre G. (A critical appraisal of) classification of hypereosinophilic disorders. Front Med (Lausanne). 2017, 4:216. 10.3389\/fmed.2017.00216","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20187419","article-title":"Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome","volume":"93","author":"Merlotto MR","year":"2018","unstructured":"Merlotto MR, Cantadori LO, Sakabe D, Miot HA. Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome. An Bras Dermatol. 2018, 93:451-3. 10.1590\/abd1806-4841.20187419","journal-title":"An Bras Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.05.026","article-title":"Lymphocyte-variant hypereosinophilic syndrome presenting as chronic dermatitis and responding to mycophenolic acid","volume":"5","author":"Dou C","year":"2019","unstructured":"Dou C, Chen LY, Dutz JP. Lymphocyte-variant hypereosinophilic syndrome presenting as chronic dermatitis and responding to mycophenolic acid. JAAD Case Rep. 2019, 5:660-2. 10.1016\/j.jdcr.2019.05.026","journal-title":"JAAD Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25617","article-title":"World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management","volume":"94","author":"Shomali W","year":"2019","unstructured":"Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019, 94:1149-67. 10.1002\/ajh.25617","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2019.11.009","article-title":"Cutaneous hypereosinophilia\u2026 Hypereosinophilic syndromes. (Article in French)","volume":"147","author":"Aubert H","year":"2020","unstructured":"Aubert H, Hamidou M, Barbarot S, Piriou N, Lefebvre M, N\u00e9el A. Cutaneous hypereosinophilia\u2026 Hypereosinophilic syndromes. (Article in French). Ann Dermatol Venereol. 2020, 147:155-66. 10.1016\/j.annder.2019.11.009","journal-title":"Ann Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000088","article-title":"The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype","volume":"93","author":"Lef\u00e8vre G","year":"2014","unstructured":"Lef\u00e8vre G, Copin MC, Staumont-Sall\u00e9 D, et al.. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype. Medicine (Baltimore). 2014, 93:255-66. 10.1097\/MD.0000000000000088","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3315\/jdcr.2014.1185","article-title":"Idiopathic hypereosinophilic syndrome: a rare cause of erythroderma","volume":"8","author":"Mahajan VK","year":"2014","unstructured":"Mahajan VK, Singh R, Mehta KS, Chauhan PS, Sharma S, Gupta M, Rawat R. Idiopathic hypereosinophilic syndrome: a rare cause of erythroderma. J Dermatol Case Rep. 2014, 8:108-14. 10.3315\/jdcr.2014.1185","journal-title":"J Dermatol Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13509","article-title":"Mechanisms of glucocorticoid resistance in hypereosinophilic syndromes","volume":"49","author":"Stokes K","year":"2019","unstructured":"Stokes K, Yoon P, Makiya M, et al.. Mechanisms of glucocorticoid resistance in hypereosinophilic syndromes. Clin Exp Allergy. 2019, 49:1598-604. 10.1111\/cea.13509","journal-title":"Clin Exp Allergy"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16332","article-title":"Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome","volume":"188","author":"Choi C","year":"2020","unstructured":"Choi C, Moller D, Tan J, et al.. Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome. Br J Haematol. 2020, 188:e68-72. 10.1111\/bjh.16332","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115006-a-lymphocytic-variant-of-hypereosinophilic-syndrome-presenting-with-isolated-cutaneous-manifestations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:31Z","timestamp":1707507631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115006-a-lymphocytic-variant-of-hypereosinophilic-syndrome-presenting-with-isolated-cutaneous-manifestations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.29745","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}